B A Werness
Overview
Explore the profile of B A Werness including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
2898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas
Afify A, Ferguson A, Davila R, Werness B
Appl Immunohistochem Mol Morphol
. 2002 Jan;
9(4):309-14.
PMID: 11759056
Experimental evidence suggests that attachment of ovarian carcinoma cells to the peritoneal mesothelium involves the interaction between CD44 on ovarian carcinoma cells and hyaluronic acid on mesothelial surfaces. The authors...
2.
Wobus M, Kuns R, Wolf C, Horn L, Kohler U, Sheyn I, et al.
Gynecol Oncol
. 2001 Oct;
83(2):227-34.
PMID: 11606076
Objective: The CD44 transmembrane glycoprotein family has been implicated in the growth and metastasis of numerous human cancers. CD44 may function in some cells through interactions with type I receptor...
3.
Werness B, Eltabbakh G
Int J Gynecol Pathol
. 2001 Feb;
20(1):48-63.
PMID: 11192072
Women with ovarian cancer have poor overall survival rates, largely because the disease is so often diagnosed at an advanced, less curable stage. Because women with early ovarian cancer experience...
4.
5.
Werness B, Ramus S, Whittemore A, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio R, et al.
Hum Pathol
. 2000 Dec;
31(11):1420-4.
PMID: 11112219
Breast cancers from patients with germline BRCA1 mutations show characteristic histopathologic features. However, similar studies of BRCA1-associated ovarian cancers have reported inconsistent findings. Interobserver differences in histopathologic classification are a...
6.
Werness B, Ramus S, Whittemore A, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio R, et al.
Int J Gynecol Pathol
. 2000 Dec;
19(4):390-4.
PMID: 11109172
Germline mutations in the BRCA1 tumor suppressor gene are associated with increased risk for the development of ovarian cancer. All such cancers thus far reported have been of the epithelial...
7.
Piver M, Tsukada Y, Werness B, DiCioccio R, Whittemore A, Ponder B
Gynecol Oncol
. 2000 Aug;
78(2):166-70.
PMID: 10926797
Objective: The aim of this study was to evaluate whether there is a significant difference in the pathology diagnoses of women in the Gilda Radner Familial Ovarian Cancer Registry between...
8.
Werness B, Parvatiyar P, Ramus S, Whittemore A, Garlinghouse-Jones K, Oakley-Girvan I, et al.
J Natl Cancer Inst
. 2000 Jul;
92(13):1088-91.
PMID: 10880552
Background: The two-hit hypothesis for the genesis of cancer predicts that cancer can develop when the wild-type allele of a tumor suppressor gene is lost in an individual with a...
9.
Loree T, North Jr J, Werness B, Nangia R, MULLINS A, Hicks Jr W
Otolaryngol Head Neck Surg
. 2000 May;
122(5):667-72.
PMID: 10793343
Malignant peripheral nerve sheath tumors of the head and neck region are uncommon and may be associated with neurofibromatosis or occur in a sporadic manner. This is a retrospective review...
10.
Werness B, Eltabbakh G
Int J Gynecol Pathol
. 2000 Apr;
19(2):190-1.
PMID: 10782421
No abstract available.